The Role of Balneotherapy in Older Adults With Chronic Low Back Pain

The Role of Balneotherapy in Older Adults With Chronic Low Back Pain: a Biopsychosocial Approach at São Pedro do Sul Thermal Baths

The effectiveness of balneotherapy in relieving chronic low back pain has been scientifically proven. This project aims to study in what extent a Balneotherapy program in São Pedro do Sul Thermal Baths influences chronic low back pain of individuals aged 65 and above, and in what order of magnitude it happens, on which domains (functional, psychological, biophysical and socioeconomic) and it's repercussions. For that, the investigators intended to carry out a project subdivided into two tasks. The first, and the most complex, with a holistic approach, will be carried out by a randomized controlled study (RCT) with focus on the various biopsychosocial domains of patients with chronic lumbar pain. Concerning the second task, another RCT will be carried out aiming for statistically significant changes in the lumbar thermographic maps before and after treatment, as well as the theoretical framework of all the findings.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Viseu
      • São Pedro do Sul, Viseu, Portugal, 3660-692
        • Termalistur - Termas de São Pedro do Sul

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 100 years (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient aged 65 and over
  • Low back pain with or without irradiation to the lower limbs with more than 3 months of evolution
  • Imaging exam of the lumbar spine that excludes neoplastic pathology or severe structural misalignments
  • Availability to carry out a 14-day treatment plan

Exclusion Criteria:

  • Can't read and write
  • History of fracture, surgery, infection or neoplasm in the spine
  • Scoliosis with a cobb angle >20
  • Lower limb muscle strength or vesico-sphincter changes
  • Fever, history of recent violent trauma, unexplained weight loss, night sweats, or persistent night pain
  • Others: unstable angina pectoris, poorly controlled hypertension, cardiac decompensation, respiratory failure, endocrine disorder, acute febrile condition, skin infections, fecal or urinary incontinence and psychosis or decompensated neurosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Group 1 - Physiotherapy modalities
parafango in the lumbar region 20min/day; High frequency Transcutaneous Electrical Nerve Stimulation (TENS), 100 Hz, 0,04-0,2mseg, 20 min/day; lumbar flexibility self-exercise plan
Experimental: Group 2 - Physiotherapy modalities + Balneotherapy modalities
parafango in the lumbar region 20min/day; High frequency Transcutaneous Electrical Nerve Stimulation (TENS), 100 Hz, 0,04-0,2mseg, 20 min/day; lumbar flexibility self-exercise plan
Immersion in a thermal pool with 15 minutes of automatic hydromassage and 15 minutes of spine flexibility exercises; thermal steam treatment to spinal column; hydromassage bath with Vichy thermal water

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numerical Rating Scale
Time Frame: two weeks
Pain assessment; From "0" (minimum - better) to "10" (maximum - worse)
two weeks
Oswestry Disability Index, version 2.0
Time Frame: two weeks
Functional assessment; From "0%" (minimum - better) to "100%" (maximum - worse)
two weeks
The Short Form-36
Time Frame: two weeks
Quality of life assessment; From "0" (minimum - worse) to "100" (maximum - better)
two weeks
Center for Epidemiologic Studies Depression Scale
Time Frame: two weeks
Depression assessment; From "0" (minimum - better) to "60" (maximum - worse)
two weeks
Satisfaction with life scale - 5 items version
Time Frame: two weeks
Satisfaction with life scale assessment; From "5" (minimum - worse) to "35" (maximum - better)
two weeks
International Physical Activity Questionnaire - short version
Time Frame: two weeks
Physical activity assessment; low values (worse) vs high values (better)
two weeks
Fatigue Assessment Scale
Time Frame: two weeks
Fatigue assessment; From "10" (minimum - better) to "50" (maximum - worse)
two weeks
Dolorimeter
Time Frame: two weeks
Pain assessment; low values (worse) vs high values (better)
two weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nelson F Albuquerque, Medical Doctor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2022

Primary Completion (Actual)

February 1, 2023

Study Completion (Actual)

September 10, 2023

Study Registration Dates

First Submitted

September 30, 2021

First Submitted That Met QC Criteria

October 13, 2021

First Posted (Actual)

October 14, 2021

Study Record Updates

Last Update Posted (Estimated)

June 25, 2025

Last Update Submitted That Met QC Criteria

June 19, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Physiotherapy modalities

Subscribe